Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (295)
- Advertising (25)
- Safety monitoring and information (23)
- Manufacturing (11)
- Scheduling (national classification system) (10)
- COVID-19 (7)
- Clinical trials (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
567 result(s) found, displaying 201 to 225
-
Corporate reportsPublication of the independent expert review of MDMA and psilocybin.
-
Meeting statementsAdvisory Committee on Vaccines. Meeting statement available.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement available.
-
Corporate reportsThe Freedom of Information disclosure log gives access to information we've released in response to an FOI request.
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper Proposed refinements to the regulation of personalised medical devices.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsThe TGA 2020-21 Annual Performance Statistics Report has now been published.
-
Corporate reportsIn the past 12-18 months, the TGA has implemented a number of changes in an effort to increase and improve post-market monitoring and surveillance activities.
-
Corporate reportsThe guidelines set out the criteria which must be met for any additional manufacturing sites to be included as secondary sites on new or existing manufacturing licences.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement available
-
Meeting statementsA meeting statement is now available for the last Advisory Committee on Complementary Medicines meeting
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Corporate reports2020/21 Therapeutic Goods Advertising Compliance Annual Report has been published
-
Corporate reportsSubmissions published and summarised as part of a consultation on clarifying the regulation of 'residual activity' claims for disinfectants.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 23 August 2021.
-
Corporate reportsThis document contains practical information produced by a team from the University of Wollongong, based on their years of practical research on nicotine vaping products.
-
Corporate reportsPractical flowcharts produced by the University of Wollongong based on their years of practical research on nicotine vaping products
-
Corporate reportsOutcomes following review of consultation submissions
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
Corporate reportsThe Australian Government remains committed to the safety, health and wellbeing of all Australians.
-
Corporate reportsHighlights and Achievements from the International Engagement Strategy 2016-2020